About Krsnaa Diagnostics Limited
Data last updated: 26 September 2026
Krsnaa Diagnostics Limited is a public limited company based in Pune, Maharashtra, India. It specialises in other hospital and medical care activities, a part of the broader healthcare sector. Incorporated on 22 December 2010, the company has been in operation for over 16 years.
Registered with ROC Pune under CIN L74900PN2010PLC138068. Listed on BSE: 543328 and NSE: KRSNAA.
Capital: an authorised share capital of ₹147.16 Cr and a paid-up capital of ₹16.22 Cr. Formerly known as Krsnaa Diagnostics Private Limited and Krsna Diagnostics Private Limited. It is led by directors including Adesh Kumar Gupta and Rajendra Khivraj Mutha.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Pune, Maharashtra.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹772.77 Cr, a growth of 6.79% compared to the previous year. The net worth stands at ₹980.39 Cr (up 11.06% YoY). Total assets are valued at ₹1,584.52 Cr (up 42.75% YoY).
The company has a workforce of approximately 3,582 employees as per the latest available data. Its group structure includes 7 subsidiaries.
The company is associated with 1 brand - Krsnaa Diagnostics. As per MCA filings, the company has open charges of ₹832.76 Cr and satisfied charges of ₹388.35 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website krsnaa.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Apps
-
Registered AddressS. No. 243/A Hissa No. 6 Cts No. 4519 4519/1 Near Chinchwad Station Chinchwad Taluk, A – Haveli, Pune, Maharashtra, India – 411019
-
IndustryHealthcare, Other Hospital And Medical Care Activities
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has undergone 2 name changes throughout its history. The company was previously known as Krsnaa Diagnostics Private Limited, and Krsna Diagnostics Private Limited. The current legal name is Krsnaa Diagnostics Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Krsnaa Diagnostics Limited | Current |
| Krsnaa Diagnostics Private Limited | Previous |
| Krsna Diagnostics Private Limited | Previous |
CIN History of Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74900PN2010PLC138068, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74900PN2010PLC138068 | Current |
| U74900PN2010PTC138068 | Previous |
| U74900PN2010PLC138068 | Previous |
Associated Brands with Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited operates one associated brand: Krsnaa Diagnostics. These brands represent Krsnaa Diagnostics Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Chain of radiology & pathology laboratory centers | krsnaadiagnostics.com |
Competitors & Alternatives of Krsnaa Diagnostics Limited
Brands and companies operating in the same space as Krsnaa Diagnostics Limited include Thyrocare, Suraksha Diagnostics, Vijaya Diagnostic Centre and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Diagnostic testing centers for pathology and health screenings are operated. | Mumbai, India, India | 1996 |
|
|
Pathology, molecular diagnostics, and imaging services are provided. | Kolkata, India, India | 2005 |
|
|
Diagnostic services are offered via a chain of centers. | Hyderabad, India, India | 1981 |
|
|
Provider molecular diagnostic solutions and services | Mumbai, India, India | 2013 |
|
|
Chain of radiology & pathology laboratory centers | Pune, India, India | 2020 |
|
|
A chain of clinical laboratories is operated for diagnostic services. | Mumbai, India, India | 2007 |
|
|
Chain of diagnostic centers | Chennai, India, India | 2000 |
|
|
Medical diagnostic services are provided through a chain of centres. | Chennai, India, India | 2008 |
|
|
Offers blood tests, radiology, home collection, and online booking services. | Kolkata, India, India | 1990 |
Business Activity of Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details for Krsnaa Diagnostics Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited is audited by MS K A & Associates for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MS K A & Associates | Locked | Locked | Locked |
Complete auditor history for Krsnaa Diagnostics Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited is currently managed by 7 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Adesh Kumar Gupta
Also directs:
Grasim Industries Ltd, Anand Rathi Wealth Limited, Krsnaa Diagnostics Limited and 5 more
|
Director | 28 May 2022 | 4 Years 3 Months | Current |
|
Rajendra Khivraj Mutha
Also directs:
Krsnaa Diagnostics Limited, Samyak Seva Foundation
|
Whole-Time Director | 22 Dec 2010 | 15 Years 9 Months | Current |
| Chetan Rameshchandra Desai | Director | 25 Apr 2021 | 5 Years 5 Months | Current |
|
Prem Pradeep
Also directs:
Krsnaa Diagnostics Limited
|
Nominee Director | 08 Oct 2020 | 5 Years 11 Months | Current |
|
Yash Prithviraj Mutha
Also directs:
Krsnaa Diagnostics Limited, Kdpl Diagnostics (Ludhiana) Private Limited, Kdpl Diagnostics (Amritsar) Private Limited and 5 more
|
Managing Director | 31 Jan 2019 | 7 Years 7 Months | Current |
|
Raju Venkatraman
Also directs:
Krsnaa Diagnostics Limited, Dollar Shave Club India Llp, Prodapt Solutions Private Limited and 5 more
|
Additional Director | 25 Apr 2026 | 0 Years 5 Months | Current |
Financials of Krsnaa Diagnostics Limited FY 2025-26 filings available
Krsnaa Diagnostics Limited reported revenue of ₹772.77 Cr (up 6.79% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 773 | 724 | 625 | 487 | 455 | 61.02 | 39.14 |
| Revenue growth | +5.2% | +11.0% | +31.8% | +12.6% | +663.9% | +40.1% | +9997.0% |
| EBITDA | 212 | 190 | 144 | 122 | 131 | 18.61 | 8.87 |
| EBITDA margin | +27.4% | +26.3% | +23.1% | +25.1% | +28.9% | +30.5% | +22.7% |
| Profit before tax | 130 | 103 | 70.00 | 80.20 | 86.50 | 0.09 | (3.29) |
| Net profit | 101 | 74.13 | 56.87 | 61.97 | 68.58 | (0.09) | (4.88) |
| Net profit margin | +13.1% | +10.2% | +9.1% | +12.7% | +15.1% | -0.2% | -12.5% |
| EPS (₹) | 30.88 | 24.03 | 17.60 | 19.78 | 21.78 | 0.00 | 0.00 |
| Balance sheet | |||||||
| Total assets | 1,585 | 1,110 | 992 | 806 | 755 | 155 | 160 |
| Net worth | 980 | 883 | 810 | 739 | 684 | 75.72 | 60.92 |
| Total debt | 534 | 204 | 160 | 32.48 | 40.99 | 36.78 | 80.97 |
| Cash & bank | 361 | 68.44 | 175 | 109 | 242 | 7.20 | 37.72 |
| Net working capital | 529 | 265 | 258 | 132 | 221 | (11.67) | 30.35 |
| Cash flow | |||||||
| Cash from operations | 143 | 87.33 | 24.35 | 76.30 | 128 | 64.02 | (22.55) |
| Cash from investing | (396) | (99.61) | (129) | (109) | (241) | (53.98) | (46.53) |
| Cash from financing | 279 | 13.75 | 84.19 | (33.15) | 176 | (40.57) | 105 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 236 | 193 | 181 | 206 | 193 | 186 | 175 | 186 |
| Revenue growth (YoY) | +22.1% | +3.5% | +3.8% | +10.6% | +13.4% | +11.9% | +10.2% | +19.9% |
| Other income | 7.25 | 31.50 | 3.77 | 4.18 | 3.96 | 4.39 | 9.24 | 4.59 |
| EBITDA | 57.98 | 54.87 | 46.36 | 59.15 | 51.40 | 52.99 | 45.07 | 49.40 |
| EBITDA margin | +24.6% | +28.5% | +25.6% | +28.7% | +26.6% | +28.5% | +25.8% | +26.5% |
| Depreciation | 27.96 | 22.59 | 22.66 | 23.59 | 21.63 | 21.96 | 22.70 | 22.20 |
| Interest | 14.83 | 12.08 | 7.79 | 8.19 | 6.30 | 6.81 | 6.13 | 6.39 |
| Profit before tax | 22.44 | 51.70 | 19.68 | 31.55 | 27.43 | 28.61 | 25.48 | 25.40 |
| Tax | 5.88 | 9.99 | 4.44 | 7.62 | 6.90 | 7.93 | 6.07 | 5.81 |
| Net profit | 16.56 | 41.71 | 15.24 | 23.93 | 20.53 | 20.68 | 19.41 | 19.59 |
| EPS (₹) | 5.04 | 12.70 | 4.66 | 7.25 | 6.25 | 6.28 | 5.88 | 5.92 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 691 | 686 | 594 | 464 | 455 | 396 | 258 |
| Revenue growth | -2.2% | +9.1% | +31.9% | +6.1% | +5.9% | -18.8% | +327.6% |
| EBITDA | 213 | 197 | 146 | 124 | 135 | 93.81 | (114) |
| EBITDA margin | +30.8% | +28.7% | +24.6% | +26.8% | +29.6% | +23.7% | -44.2% |
| Profit before tax | 132 | 110 | 71.94 | 82.19 | 89.59 | 295 | (158) |
| Net profit | 103 | 79.33 | 58.60 | 63.37 | 70.89 | 185 | (112) |
| Net profit margin | +14.9% | +11.6% | +9.9% | +13.7% | +15.6% | +46.7% | -43.3% |
| EPS (₹) | 31.26 | 25.65 | 18.14 | 20.23 | 22.52 | 284.73 | (216.83) |
| Balance sheet | |||||||
| Total assets | 1,590 | 1,118 | 997 | 810 | 758 | 474 | 558 |
| Net worth | 992 | 893 | 815 | 742 | 687 | 232 | (197) |
| Total debt | 531 | 202 | 160 | 32.48 | 40.99 | 232 | 231 |
| Cash & bank | 356 | 67.91 | 175 | 108 | 242 | 153 | 127 |
| Net working capital | 546 | 276 | 264 | 137 | 224 | 128 | 141 |
| Cash flow | |||||||
| Cash from operations | 134 | 89.38 | 24.39 | 75.48 | 129 | 119 | 37.81 |
| Cash from investing | (391) | (102) | (129) | (109) | (241) | (67.37) | (76.65) |
| Cash from financing | 278 | 13.91 | 84.21 | (33.13) | 176 | 20.03 | 5.78 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 211 | 173 | 159 | 183 | 176 | 175 | 165 | 179 |
| Revenue growth (YoY) | +20.0% | -0.9% | -3.5% | +2.3% | +7.6% | +9.6% | +9.0% | +21.7% |
| Other income | 7.21 | 31.41 | 3.80 | 4.21 | 4.00 | 4.46 | 9.29 | 4.60 |
| Total expenses | 154 | 116 | 112 | 125 | 126 | 121 | 117 | 126 |
| EBITDA | 56.73 | 56.83 | 47.67 | 58.00 | 50.10 | 53.30 | 47.90 | 52.48 |
| EBITDA margin | +26.9% | +32.8% | +29.9% | +31.7% | +28.5% | +30.5% | +29.0% | +29.4% |
| Depreciation | 27.70 | 22.25 | 22.53 | 23.47 | 21.51 | 21.80 | 22.69 | 22.20 |
| Interest | 14.72 | 11.86 | 7.72 | 8.12 | 6.25 | 6.75 | 6.13 | 6.39 |
| Profit before tax | 21.52 | 54.13 | 21.22 | 30.62 | 26.34 | 29.21 | 28.37 | 28.49 |
| Tax | 5.70 | 10.75 | 4.73 | 7.40 | 6.78 | 8.15 | 6.77 | 6.53 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 236 | 193 | 181 | 206 | 193 | 186 | 175 | 186 |
| Revenue growth (YoY) | +22.1% | +3.5% | +3.8% | +10.6% | +13.4% | +11.9% | +10.2% | +19.9% |
| Other income | 7.25 | 31.50 | 3.77 | 4.18 | 3.96 | 4.39 | 9.24 | 4.59 |
| EBITDA | 57.98 | 54.87 | 46.36 | 59.15 | 51.40 | 52.99 | 45.07 | 49.40 |
| EBITDA margin | +24.6% | +28.5% | +25.6% | +28.7% | +26.6% | +28.5% | +25.8% | +26.5% |
| Depreciation | 27.96 | 22.59 | 22.66 | 23.59 | 21.63 | 21.96 | 22.70 | 22.20 |
| Interest | 14.83 | 12.08 | 7.79 | 8.19 | 6.30 | 6.81 | 6.13 | 6.39 |
| Profit before tax | 22.44 | 51.70 | 19.68 | 31.55 | 27.43 | 28.61 | 25.48 | 25.40 |
| Tax | 5.88 | 9.99 | 4.44 | 7.62 | 6.90 | 7.93 | 6.07 | 5.81 |
| Net profit | 16.56 | 41.71 | 15.24 | 23.93 | 20.53 | 20.68 | 19.41 | 19.59 |
| EPS (₹) | 5.04 | 12.70 | 4.66 | 7.25 | 6.25 | 6.28 | 5.88 | 5.92 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Revenue | 773 | 724 | 625 | 487 | 455 | 61.02 | 39.14 |
| Revenue growth | +5.2% | +11.0% | +31.8% | +12.6% | +663.9% | +40.1% | +9997.0% |
| Other income | 43.39 | 25.54 | 16.80 | 19.38 | 14.91 | 2.34 | 3.23 |
| Total expenses | 561 | 534 | 481 | 365 | 324 | 42.41 | 30.27 |
| Employee cost | 0.00 | 137 | 111 | 74.56 | 54.15 | 12.50 | 9.00 |
| EBITDA | 212 | 190 | 144 | 122 | 131 | 18.61 | 8.87 |
| EBITDA margin | +27.4% | +26.3% | +23.1% | +25.1% | +28.9% | +30.5% | +22.7% |
| Depreciation | 90.46 | 88.32 | 74.55 | 53.78 | 41.39 | 11.58 | 6.44 |
| Interest | 34.36 | 24.65 | 16.49 | 7.70 | 18.49 | 9.28 | 8.95 |
| Profit before tax | 130 | 103 | 70.00 | 80.20 | 86.50 | 0.09 | (3.29) |
| Tax | 28.93 | 25.08 | 13.17 | 18.09 | 18.12 | 0.18 | 1.61 |
| Net profit | 101 | 74.13 | 56.87 | 61.97 | 68.58 | (0.09) | (4.88) |
| Net profit margin | +13.1% | +10.2% | +9.1% | +12.7% | +15.1% | -0.2% | -12.5% |
| EPS (₹) | 30.88 | 24.03 | 17.60 | 19.78 | 21.78 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 16.22 | 16.15 | 16.15 | 15.70 | 15.70 | 70.15 | 55.12 |
| Reserves & surplus | 964 | 867 | 794 | 723 | 669 | 5.57 | 5.80 |
| Shareholders' funds (net worth) | 980 | 883 | 810 | 739 | 684 | 75.72 | 60.92 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 479 | 26.97 | 11.00 | 16.50 | 25.63 | 32.38 | 78.55 |
| Unsecured loans | 55.11 | 177 | 149 | 15.98 | 15.36 | 4.40 | 2.42 |
| Total debt | 534 | 204 | 160 | 32.48 | 40.99 | 36.78 | 80.97 |
| Total liabilities | 1,585 | 1,110 | 992 | 806 | 755 | 155 | 160 |
| Assets | |||||||
| Gross block | 1,042 | 971 | 874 | 627 | 491 | 160 | 91.54 |
| Net block | 656 | 670 | 647 | 471 | 386 | 131 | 74.02 |
| Capital work in progress | 208 | 2.96 | 9.85 | 25.48 | 28.26 | 5.78 | 20.05 |
| Investments | 57.43 | 31.54 | 0.29 | 0.29 | 0.29 | 0.57 | 0.53 |
| Inventories | 26.66 | 29.48 | 35.81 | 25.07 | 9.17 | 0.95 | 0.67 |
| Sundry debtors | 296 | 278 | 176 | 73.10 | 57.87 | 14.11 | 8.44 |
| Cash & bank balances | 361 | 68.44 | 175 | 109 | 242 | 7.20 | 37.72 |
| Loans & advances | 55.46 | 38.82 | 33.90 | 15.95 | 25.22 | 3.36 | 9.38 |
| Total current assets | 738 | 414 | 421 | 223 | 334 | 25.62 | 56.21 |
| Total current liabilities | 209 | 149 | 164 | 90.99 | 113 | 37.29 | 25.86 |
| Net working capital | 529 | 265 | 258 | 132 | 221 | (11.67) | 30.35 |
| Total assets | 1,585 | 1,110 | 992 | 806 | 755 | 155 | 160 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Opening cash | 3.85 | 2.38 | 22.72 | 88.45 | 24.68 | 37.72 | 1.40 |
| Net cash from operating activities | 143 | 87.33 | 24.35 | 76.30 | 128 | 64.02 | (22.55) |
| Net cash from investing activities | (396) | (99.61) | (129) | (109) | (241) | (53.98) | (46.53) |
| Net cash from financing activities | 279 | 13.75 | 84.19 | (33.15) | 176 | (40.57) | 105 |
| Net change in cash | 26.38 | 1.47 | (20.35) | (65.73) | 63.78 | (30.53) | 36.33 |
| Closing cash | 361 | 68.44 | 175 | 109 | 242 | 7.20 | 37.72 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +6.8% | +15.8% | +28.3% | +7.0% | +646.4% | +55.9% | +9997.0% |
| EBITDA growth | +11.4% | +31.8% | +17.9% | -7.0% | +606.5% | +109.8% | +9997.0% |
| PBT growth | +27.0% | +46.7% | -12.7% | -7.3% | - | +9998.0% | +9997.0% |
| Net income growth | +36.8% | +30.4% | -8.2% | -9.6% | +9998.0% | +98.2% | +9997.0% |
| Revenue CAGR (3Y) | +16.6% | +16.7% | +117.2% | +131.7% | - | - | - |
| EBITDA CAGR (3Y) | +20.1% | +13.1% | +97.9% | +139.8% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +13.1% | +10.7% | +9.1% | +12.8% | +15.0% | -0.2% | -12.5% |
| Return on capital employed | - | +12.1% | +9.6% | +11.3% | +13.9% | 0.0% | 0.0% |
| Return on net worth | - | +9.2% | +7.3% | +8.7% | +10.0% | 0.0% | 0.0% |
| Debt / equity | - | 0.21 | 0.12 | 0.05 | 0.06 | 0.86 | 1.33 |
| Long-term debt / equity | - | 0.05 | 0.04 | 0.04 | 0.05 | 0.39 | 0.53 |
| Interest cover | 28.32 | 24.21 | 23.66 | 11.24 | 20.53 | 132.01 | 368.31 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.78 | 0.83 | 0.87 | 0.93 | 0.49 | 0.43 |
| Inventory turnover | - | 22.17 | 20.54 | 28.45 | 49.67 | 75.33 | 58.42 |
| Debtors turnover | - | 3.19 | 5.01 | 7.44 | 7.87 | 5.41 | 4.64 |
| EPS (₹) | 30.88 | 24.03 | 17.60 | 19.78 | 21.78 | 0.00 | 0.00 |
| Dividend per share (₹) | 2.00 | 2.75 | 2.50 | 2.75 | 2.50 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 273.39 | 250.79 | 235.28 | 217.98 | 20.79 | 21.24 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 211 | 173 | 159 | 183 | 176 | 175 | 165 | 179 |
| Revenue growth (YoY) | +20.0% | -0.9% | -3.5% | +2.3% | +7.6% | +9.6% | +9.0% | +21.7% |
| Other income | 7.21 | 31.41 | 3.80 | 4.21 | 4.00 | 4.46 | 9.29 | 4.60 |
| Total expenses | 154 | 116 | 112 | 125 | 126 | 121 | 117 | 126 |
| EBITDA | 56.73 | 56.83 | 47.67 | 58.00 | 50.10 | 53.30 | 47.90 | 52.48 |
| EBITDA margin | +26.9% | +32.8% | +29.9% | +31.7% | +28.5% | +30.5% | +29.0% | +29.4% |
| Depreciation | 27.70 | 22.25 | 22.53 | 23.47 | 21.51 | 21.80 | 22.69 | 22.20 |
| Interest | 14.72 | 11.86 | 7.72 | 8.12 | 6.25 | 6.75 | 6.13 | 6.39 |
| Profit before tax | 21.52 | 54.13 | 21.22 | 30.62 | 26.34 | 29.21 | 28.37 | 28.49 |
| Tax | 5.70 | 10.75 | 4.73 | 7.40 | 6.78 | 8.15 | 6.77 | 6.53 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 691 | 686 | 594 | 464 | 455 | 396 | 258 |
| Revenue growth | -2.2% | +9.1% | +31.9% | +6.1% | +5.9% | -18.8% | +327.6% |
| Other income | 43.41 | 25.67 | 16.80 | 19.41 | 14.93 | 265 | 12.95 |
| Total expenses | 478 | 489 | 448 | 340 | 320 | 303 | 373 |
| Employee cost | 0.00 | 112 | 97.57 | 65.63 | 52.74 | 29.91 | 23.13 |
| EBITDA | 213 | 197 | 146 | 124 | 135 | 93.81 | (114) |
| EBITDA margin | +30.8% | +28.7% | +24.6% | +26.8% | +29.6% | +23.7% | -44.2% |
| Depreciation | 89.76 | 88.16 | 74.55 | 53.78 | 41.39 | 37.44 | 32.41 |
| Interest | 33.94 | 24.57 | 16.47 | 7.68 | 18.49 | 25.94 | 24.66 |
| Profit before tax | 132 | 110 | 71.94 | 82.19 | 89.59 | 295 | (158) |
| Tax | 29.65 | 26.79 | 13.38 | 18.68 | 18.90 | 111 | (46.38) |
| Net profit | 103 | 79.33 | 58.60 | 63.37 | 70.89 | 185 | (112) |
| Net profit margin | +14.9% | +11.6% | +9.9% | +13.7% | +15.6% | +46.7% | -43.3% |
| EPS (₹) | 31.26 | 25.65 | 18.14 | 20.23 | 22.52 | 284.73 | (216.83) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 16.22 | 16.15 | 16.15 | 15.70 | 15.70 | 249 | 20.19 |
| Reserves & surplus | 967 | 871 | 797 | 724 | 671 | (17.02) | (217) |
| Shareholders' funds (net worth) | 992 | 893 | 815 | 742 | 687 | 232 | (197) |
| Secured loans | 491 | 166 | 107 | 16.50 | 25.63 | 213 | 229 |
| Unsecured loans | 40.63 | 36.08 | 53.07 | 15.98 | 15.36 | 18.75 | 2.20 |
| Total debt | 531 | 202 | 160 | 32.48 | 40.99 | 232 | 231 |
| Total liabilities | 1,590 | 1,118 | 997 | 810 | 758 | 474 | 558 |
| Assets | |||||||
| Gross block | 1,036 | 968 | 874 | 627 | 491 | 377 | 308 |
| Net block | 651 | 668 | 647 | 471 | 386 | 309 | 275 |
| Capital work in progress | 208 | 2.96 | 9.85 | 25.48 | 28.26 | 3.72 | 9.13 |
| Investments | 57.50 | 31.62 | 0.36 | 0.36 | 0.36 | 0.29 | 0.29 |
| Inventories | 25.66 | 29.48 | 35.81 | 25.07 | 9.17 | 7.21 | 5.07 |
| Sundry debtors | 308 | 283 | 178 | 74.55 | 59.31 | 75.29 | 61.43 |
| Cash & bank balances | 356 | 67.91 | 175 | 108 | 242 | 153 | 127 |
| Loans & advances | 54.68 | 38.56 | 33.86 | 15.92 | 25.53 | 17.47 | 19.85 |
| Total current assets | 744 | 419 | 422 | 224 | 336 | 253 | 214 |
| Total current liabilities | 198 | 143 | 158 | 87.05 | 112 | 125 | 72.26 |
| Net working capital | 546 | 276 | 264 | 137 | 224 | 128 | 141 |
| Total assets | 1,590 | 1,118 | 997 | 810 | 758 | 474 | 558 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 3.32 | 1.86 | 22.13 | 88.32 | 24.68 | (46.65) | (14.52) |
| Net cash from operating activities | 134 | 89.38 | 24.39 | 75.48 | 129 | 119 | 37.81 |
| Net cash from investing activities | (391) | (102) | (129) | (109) | (241) | (67.37) | (76.65) |
| Net cash from financing activities | 278 | 13.91 | 84.21 | (33.13) | 176 | 20.03 | 5.78 |
| Net change in cash | 21.73 | 1.46 | (20.27) | (66.19) | 63.65 | 71.32 | (33.06) |
| Closing cash | 25.05 | 67.91 | 175 | 108 | 242 | 153 | 127 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +0.8% | +15.4% | +28.1% | +2.0% | +14.7% | +53.4% | +75.9% |
| EBITDA growth | +8.1% | +34.6% | +17.6% | -7.7% | +43.4% | +9998.0% | - |
| PBT growth | +20.7% | +52.4% | -12.5% | -8.3% | -69.7% | +9998.0% | - |
| Net income growth | +29.4% | +35.4% | -7.5% | -10.6% | -61.7% | +9998.0% | - |
| Revenue CAGR (3Y) | +14.2% | +14.7% | +14.5% | +21.6% | +45.8% | +91.0% | +93.6% |
| EBITDA CAGR (3Y) | +19.6% | +13.5% | +15.9% | - | +31.1% | +86.3% | - |
| Profitability & leverage | |||||||
| Net income margin | +14.9% | +12.1% | +9.9% | +13.7% | +15.5% | +46.6% | -43.3% |
| Return on capital employed | - | +12.7% | +9.8% | +11.5% | +17.0% | +59.9% | 0.0% |
| Return on net worth | - | +9.7% | +7.5% | +8.9% | +19.7% | -204.0% | 0.0% |
| Debt / equity | - | 0.21 | 0.12 | 0.05 | 0.30 | 13.27 | 0.00 |
| Long-term debt / equity | - | 0.05 | 0.04 | 0.04 | 0.22 | 8.80 | 0.00 |
| Interest cover | 27.63 | 22.65 | 23.00 | 10.90 | 19.85 | 46.02 | -16.82 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.74 | 0.79 | 0.83 | 1.05 | 1.16 | 0.87 |
| Inventory turnover | - | 21.01 | 19.53 | 27.11 | 55.54 | 64.57 | 55.70 |
| Debtors turnover | - | 2.97 | 4.71 | 6.93 | 6.76 | 5.80 | 4.39 |
| EPS (₹) | 31.26 | 25.65 | 18.14 | 20.23 | 22.52 | 284.73 | (216.83) |
| Dividend per share (₹) | 2.00 | 2.75 | 2.50 | 2.75 | 2.50 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 274.65 | 251.73 | 235.63 | 218.72 | (16.20) | (410.62) |
Shareholding Pattern of Krsnaa Diagnostics Limited
As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 27.10%, foreign institutional investors hold 4.30%, domestic institutional investors hold 14.50%, retail and other public shareholders hold 54.10% of Krsnaa Diagnostics Limited.
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | |
|---|---|---|---|---|
| Promoters | 27.10% | 27.10% | 27.10% | 27.10% |
| Public | 72.90% | 72.90% | 72.90% | 72.90% |
Group Structure of Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has 7 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Krsnaa Diagnostics Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Kdpl Diagnostics (Ludhiana) Private Limited | U85100PN2021PTC199690 | - |
| Kdpl Diagnostics (Amritsar) Private Limited | U85100PN2021PTC199780 | - |
| Kdpl Diagnostics (Bathinda) Private Limited | U85100PN2021PTC199781 | - |
| Kdpl Diagnostics (Jalandhar) Private Limited | U85100PN2021PTC199783 | - |
| Kdpl Diagnostics (Patiala) Private Limited | U85100PN2021PTC199785 | - |
| Kdpl Diagnostics (Sas Nagar) Private Limited | U85110PN2021PTC199787 | - |
Showing major subsidiaries. Total: 7.
Charges & Borrowings of Krsnaa Diagnostics Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jan 2026 | Others | ₹430 Cr | Open |
| 20 Sep 2025 | Others | ₹50 Cr | Open |
| 11 Nov 2024 | Hdfc Bank Limited | ₹120 Cr | Open |
| 08 Aug 2024 | Others | ₹20 Cr | Open |
| 21 Feb 2024 | Yes Bank Limited | ₹23.75 Cr | Open |
Total charge records: 48 View all charges
Employees and EPFO Compliance at Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited has a workforce of 3,582 employees as of Aug 02, 2025.
Employee and EPFO history for Krsnaa Diagnostics Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Krsnaa Diagnostics Limited
GST registrations and filing compliance for Krsnaa Diagnostics Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Krsnaa Diagnostics Limited
Credit ratings, litigation, and regulatory alerts for Krsnaa Diagnostics Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Krsnaa Diagnostics Limited
MSME payment history for Krsnaa Diagnostics Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Krsnaa Diagnostics Limited
Corporate group structure for Krsnaa Diagnostics Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Krsnaa Diagnostics Limited
MCA filings and documents for Krsnaa Diagnostics Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Krsnaa Diagnostics Limited
Recent News on Krsnaa Diagnostics Limited
Frequently Asked Questions about Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited is an active public limited company in the healthcare sector based in Pune, Maharashtra, India. It was incorporated on 22 December 2010 (16+ years old) and is registered under CIN L74900PN2010PLC138068. Listed on BSE: 543328 and NSE: KRSNAA. The company has 3,582 employees.
Krsnaa Diagnostics Limited reported revenue of ₹772.77 Cr for FY 2025-26 (up 6.79% YoY) based on consolidated financials.
The current directors of Krsnaa Diagnostics Limited are:
- Adesh Kumar Gupta - Director
- Rajendra Khivraj Mutha - Whole-Time Director
- Chetan Rameshchandra Desai - Director
- Prem Pradeep - Nominee Director
- Yash Prithviraj Mutha - Managing Director
- Raju Venkatraman - Additional Director
- Lilian Jessie Paul - Additional Director
The primary industry of Krsnaa Diagnostics Limited is healthcare. The company specifically operates in other hospital and medical care activities. The company is currently active in this sector.
Yes. Krsnaa Diagnostics Limited is listed on both BSE (code: 543328) and NSE (symbol: KRSNAA).
Krsnaa Diagnostics Limited can be reached at the registered office: S. No. 243A Hissa No. 6 Cts No. 4519 45191 Near Chinchwad Station Chinchwad Taluk, A – Haveli, Pune, Maharashtra, India – 411019, or through the website krsnaa.in.